Xin‐Fei Xu

1.2k total citations · 1 hit paper
23 papers, 705 citations indexed

About

Xin‐Fei Xu is a scholar working on Epidemiology, Hepatology and Cancer Research. According to data from OpenAlex, Xin‐Fei Xu has authored 23 papers receiving a total of 705 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 13 papers in Hepatology and 7 papers in Cancer Research. Recurrent topics in Xin‐Fei Xu's work include Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Liver Disease Diagnosis and Treatment (11 papers) and Cancer, Lipids, and Metabolism (7 papers). Xin‐Fei Xu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Liver Disease Diagnosis and Treatment (11 papers) and Cancer, Lipids, and Metabolism (7 papers). Xin‐Fei Xu collaborates with scholars based in China, Hong Kong and United States. Xin‐Fei Xu's co-authors include Feng Shen, Tian Yang, Mengchao Wu, Ya-Hao Zhou, Wei‐Min Gu, Ting‐Hao Chen, Hao Xing, Yongyi Zeng, Chao Li and Jun Han and has published in prestigious journals such as Advanced Materials, Journal of Clinical Oncology and Small.

In The Last Decade

Xin‐Fei Xu

18 papers receiving 700 citations

Hit Papers

Risk Factors, Patterns, a... 2018 2026 2020 2023 2018 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xin‐Fei Xu China 11 449 248 160 159 152 23 705
Jiayan Ni China 12 383 0.9× 190 0.8× 67 0.4× 74 0.5× 140 0.9× 26 537
Kiyohiko Omichi Japan 18 346 0.8× 163 0.7× 293 1.8× 48 0.3× 345 2.3× 33 748
Yosuke Nakao Japan 14 160 0.4× 87 0.4× 245 1.5× 87 0.5× 210 1.4× 43 623
Zilin Huang China 13 175 0.4× 64 0.3× 149 0.9× 109 0.7× 145 1.0× 33 524
Ningyang Jia China 13 160 0.4× 104 0.4× 98 0.6× 50 0.3× 188 1.2× 39 495
Amane Takahashi Japan 12 115 0.3× 77 0.3× 180 1.1× 169 1.1× 113 0.7× 36 585
Bao Jin China 15 130 0.3× 91 0.4× 267 1.7× 99 0.6× 157 1.0× 47 660
Qungang Shan China 13 153 0.3× 106 0.4× 59 0.4× 57 0.4× 70 0.5× 24 432
Shengping Li China 13 101 0.2× 115 0.5× 278 1.7× 105 0.7× 239 1.6× 28 565

Countries citing papers authored by Xin‐Fei Xu

Since Specialization
Citations

This map shows the geographic impact of Xin‐Fei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin‐Fei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin‐Fei Xu more than expected).

Fields of papers citing papers by Xin‐Fei Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xin‐Fei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin‐Fei Xu. The network helps show where Xin‐Fei Xu may publish in the future.

Co-authorship network of co-authors of Xin‐Fei Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Xin‐Fei Xu. A scholar is included among the top collaborators of Xin‐Fei Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xin‐Fei Xu. Xin‐Fei Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Xu, Xin‐Fei, Ya-Hao Zhou, & Tian Yang. (2025). ASO Author Reflections: Reconsidering Late Recurrence After Hepatectomy for Hepatocellular Carcinoma: Insights from Predictive Modeling. Annals of Surgical Oncology. 32(13). 9632–9633.
3.
Xu, Xin‐Fei, Han Wu, Ya-Hao Zhou, et al.. (2025). Development and Validation of an Individualized Prediction Model for Postoperative Late Recurrence After Hepatectomy for Hepatocellular Carcinoma (POLAR-HCC): A Multicenter Study. Annals of Surgical Oncology. 32(13). 9573–9583. 2 indexed citations
5.
Xu, Jiahao, Faji Yang, Zhi-Peng Liu, et al.. (2024). A Novel Liver Metastasis Score for Patients Undergoing Surgical Resection of Gastroenteropancreatic Neuroendocrine Tumors: A Multi-institutional Study. Annals of Surgical Oncology. 32(2). 1176–1186.
6.
Yang, Tian, Yong‐Kang Diao, Ming-Da Wang, et al.. (2024). Prognostic Value of the ASAP Score for Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma: A Multicenter Analysis of 1,239 Patients. Journal of Clinical and Experimental Hepatology. 15(3). 102497–102497.
8.
Wu, Han, Li Xu, Xin‐Fei Xu, et al.. (2023). Hydrogel Crosslinked with Nanoparticles for Prevention of Surgical Hemorrhage and Recurrence of Hepatocellular Carcinoma. Advanced Science. 11(9). e2305508–e2305508. 13 indexed citations
9.
Wu, Han, Xin‐Fei Xu, Hao Xing, et al.. (2022). Responsive Hydrogels Based on Triggered Click Reactions for Liver Cancer. Advanced Materials. 34(38). e2201651–e2201651. 66 indexed citations
10.
Yao, Lan‐Qing, Zhengliang Chen, Yong‐Kang Diao, et al.. (2022). Clinical Features of Recurrence After Hepatic Resection for Early-Stage Hepatocellular Carcinoma and Long-Term Survival Outcomes of Patients with Recurrence: A Multi-institutional Analysis. Annals of Surgical Oncology. 29(7). 4291–4303. 45 indexed citations
11.
Liu, Zhi-Peng, Lan‐Qing Yao, Yong‐Kang Diao, et al.. (2022). Association of Preoperative Body Mass Index with Surgical Textbook Outcomes Following Hepatectomy for Hepatocellular Carcinoma: A Multicenter Study of 1206 Patients. Annals of Surgical Oncology. 29(7). 4278–4286. 18 indexed citations
13.
Yan, Wentao, Chao Li, Lan‐Qing Yao, et al.. (2021). Predictors and long-term prognosis of early and late recurrence for patients undergoing hepatic resection of hepatocellular carcinoma: a large-scale multicenter study. HepatoBiliary Surgery and Nutrition. 12(2). 155–168. 29 indexed citations
14.
Wu, Han, Xin‐Fei Xu, Ming-Da Wang, et al.. (2021). Mesoporous Silica Nanoparticles for Potential Immunotherapy of Hepatocellular Carcinoma. Frontiers in Bioengineering and Biotechnology. 9. 695635–695635. 13 indexed citations
16.
Wu, Han, Xin‐Fei Xu, Hao Xing, et al.. (2021). Biointerfacing Antagonizing T‐Cell Inhibitory Nanoparticles Potentiate Hepatocellular Carcinoma Checkpoint Blockade Therapy. Small. 17(51). e2105237–e2105237. 10 indexed citations
17.
Wang, Ming-Da, Hao Xing, Chao Li, et al.. (2020). A novel role of Krüppel-like factor 8 as an apoptosis repressor in hepatocellular carcinoma. Cancer Cell International. 20(1). 422–422. 7 indexed citations
18.
Wang, Ming-Da, Chao Li, Lei Liang, et al.. (2020). Early and Late Recurrence of Hepatitis B Virus-Associated Hepatocellular Carcinoma. The Oncologist. 25(10). e1541–e1551. 79 indexed citations
19.
Li, Zhenli, Han Wu, Yongpeng Wei, et al.. (2019). Impact of Surveillance in Chronic Hepatitis B Patients on Long-Term Outcomes After Curative Liver Resection for Hepatocellular Carcinoma. Journal of Gastrointestinal Surgery. 24(9). 1987–1995. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026